Everlywell Heart Health Test: At-Home Cardiovascular Biomarker Screening

Cardiovascular disease kills more people worldwide than any other condition, yet the blood biomarkers that predict it years in advance remain invisible to most people between annual physicals. At-home testing is changing that equation.

Presented By Our Partners

Nearly half of all heart attacks and strokes occur in people who were never told their cardiovascular risk was elevated. The standard lipid panel, a test that has existed for decades, can identify dyslipidemia years before a cardiac event. Add high-sensitivity C-reactive protein (hsCRP), a marker of systemic inflammation that independently predicts cardiovascular risk even when cholesterol levels appear normal, and you have a screening profile that the broader medical research community considers essential for primary prevention. Yet millions of adults go years between blood draws, either because they lack insurance coverage for regular testing, cannot schedule a physician visit, or simply do not prioritize preventive screening until symptoms appear.

The Everlywell Heart Health Test is one of a growing number of direct-to-consumer blood testing platforms designed to close that gap. By delivering a finger-prick collection kit to your door, processing samples through CLIA-certified laboratories, and returning physician-reviewed results within days, Everlywell makes cardiovascular biomarker screening accessible to anyone willing to spend $99 and prick a finger. The question is whether convenience and accessibility translate to clinical utility.

What Is the Everlywell Heart Health Test?

The Everlywell Heart Health Test is an at-home blood collection kit that measures key cardiovascular biomarkers from a dried blood spot sample obtained via finger prick. Depending on the panel selected, biomarkers may include total cholesterol, LDL cholesterol (calculated), HDL cholesterol, triglycerides, high-sensitivity C-reactive protein (hsCRP), and hemoglobin A1c (HbA1c). The test is part of Everlywell’s broader catalog of more than 30 at-home health tests covering categories from food sensitivity to thyroid function.

The testing process is straightforward. Everlywell ships a collection kit with lancets, a blood collection card, prepaid return packaging, and step-by-step instructions. The user collects a small blood sample via finger prick, applies it to the collection card, and mails it to a CLIA-certified partner laboratory. Results are typically available within five to seven business days through Everlywell’s online dashboard. Every result is reviewed by a physician in the user’s state, and the dashboard provides reference ranges, trend tracking for repeat testers, and general health education context.

Everlywell does not require a prescription, insurance, or a physician visit to order. Tests are available directly through the company’s website, and prices for heart health panels range from $99 to $249 depending on the breadth of biomarkers included. All Everlywell tests are HSA and FSA eligible.

The Science Behind Blood Biomarker Screening for Cardiovascular Risk

The clinical rationale for the biomarkers measured by the Everlywell Heart Health Test rests on decades of cardiovascular epidemiology. Each marker in the panel addresses a distinct dimension of cardiac risk, and together they provide a more complete picture than any single measurement alone.

LDL cholesterol remains the primary target of cardiovascular risk management in major clinical guidelines worldwide. Elevated LDL drives atherogenesis, the accumulation of lipid-laden plaques within arterial walls that narrow blood vessels and, when unstable, rupture to cause heart attacks and strokes. The relationship is causal, dose-dependent, and temporal: the longer LDL remains elevated, the greater the cumulative damage. Statin therapy, which lowers LDL, has reduced cardiovascular events by 25% to 35% in major randomized trials.

High-sensitivity C-reactive protein adds a dimension that lipid testing alone misses. hsCRP is a marker of systemic inflammation produced by the liver in response to inflammatory cytokines. The JUPITER trial (2008), a landmark randomized controlled trial of 17,802 apparently healthy individuals with elevated hsCRP but normal LDL cholesterol, demonstrated that statin therapy reduced major cardiovascular events by 44% in this population. This finding established that inflammation, independent of cholesterol, drives cardiovascular events in a substantial subset of the population.

According to PubMed, a 2011 expert panel consensus published in the Journal of Clinical Lipidology by Davidson et al., convened by the National Lipid Association, evaluated the clinical utility of inflammatory markers and advanced lipoprotein testing. The panel concluded that hsCRP and LDL particle concentration provide meaningful risk stratification beyond standard lipid panels, particularly for patients with metabolic syndrome, low HDL cholesterol, and elevated triglycerides (DOI).

Hemoglobin A1c, which reflects average blood glucose over the preceding two to three months, bridges cardiovascular and metabolic risk assessment. Elevated HbA1c indicates insulin resistance or diabetes, both of which dramatically accelerate atherosclerosis. The broader medical research community recognizes HbA1c above 5.7% as prediabetic and above 6.5% as diabetic, with each 1% increase in HbA1c above normal associated with a roughly 18% increase in cardiovascular event risk in large meta-analyses.

The HDL-to-triglyceride ratio, calculable from the Everlywell panel, has emerged as a practical proxy for insulin resistance and atherogenic dyslipidemia. A ratio above 2.0 (triglycerides divided by HDL in mg/dL) suggests a metabolic pattern associated with small, dense LDL particles, which are more atherogenic than large, buoyant LDL, even at the same total LDL concentration.

That is the science. Here is how the Everlywell Heart Health Test applies it.

What the Everlywell Heart Health Test Does Well

Everlywell’s primary strength is access. The test removes the three most common barriers to cardiovascular screening: the need for a physician visit, the need for insurance authorization, and the need to schedule a phlebotomy appointment. For the estimated 27 million Americans without a primary care physician, or the many millions more who have one but go years between visits, a $99 finger-prick test that arrives in the mail and returns physician-reviewed results within a week represents a genuine reduction in friction.

The CLIA certification of Everlywell’s partner laboratories provides a baseline quality assurance that distinguishes clinical-grade testing from wellness gimmicks. CLIA certification requires laboratories to meet federal standards for proficiency testing, personnel qualifications, and quality control. While finger-prick dried blood spot collection introduces slightly more variability than a standard venipuncture draw, the methodology has been used in population health screening for over 30 years and has been validated for lipid and HbA1c measurement.

The physician review requirement is a meaningful safety feature. Every Everlywell result is reviewed by a board-certified physician in the user’s state before release. If results indicate a clinically significant abnormality, the reviewing physician can flag it and recommend follow-up. This is not a substitute for an ongoing patient-physician relationship, but it provides a clinical safety net that purely algorithmic platforms lack.

HSA and FSA eligibility across all Everlywell tests makes the cost tax-advantaged for the millions of Americans with health savings accounts, effectively reducing the out-of-pocket expense by 20% to 35% depending on the user’s tax bracket.

Featured Partner

Invest in the Infrastructure Behind Modern Medicine

As healthcare expands beyond hospital walls, the buildings and campuses supporting that shift are generating compelling returns for investors who move early. The Healthcare Real Estate Fund offers qualified investors direct access to a curated portfolio of medical office, outpatient, and specialty care facilities.

Learn More →

Pricing, Access, and Practical Realities

The Everlywell Heart Health Test starts at $99 for the basic panel. More comprehensive panels that include additional biomarkers such as HbA1c and hsCRP alongside the standard lipid panel range up to $249. No subscription is required, though Everlywell offers membership pricing for users who plan to test regularly. There are no hidden fees; the price includes the collection kit, laboratory processing, physician review, and digital results.

First-year cost depends on testing frequency. A single baseline test costs $99 to $249. Quarterly testing, which provides meaningful trend data, would cost $396 to $996 annually. By comparison, a standard lipid panel ordered through a physician visit typically costs $50 to $200 after insurance, plus the co-pay for the office visit itself (averaging $20 to $75).

All Everlywell tests are confirmed HSA and FSA eligible, and the company provides the documentation needed for reimbursement. No prescription is required to order.

Regarding regulatory status, Everlywell’s laboratory partners hold CLIA certification and state licenses required for clinical laboratory operations. The tests themselves are laboratory-developed tests (LDTs) processed in certified facilities. Everlywell is not an FDA-cleared diagnostic device; it is a sample collection and logistics platform that connects consumers to certified laboratories. This distinction matters: the laboratory results carry clinical validity, but the at-home collection process introduces a user-dependent variable that clinical phlebotomy does not.

Who the Everlywell Heart Health Test Is Best For

The Everlywell Heart Health Test serves several user profiles well. Adults without a current physician relationship who want baseline cardiovascular screening benefit most from the zero-friction ordering process. Health-conscious individuals who want to track lipid and inflammatory markers between annual physicals gain trend data that a single yearly test cannot provide. People in rural areas or with limited access to laboratory facilities find the mail-in format eliminates geographic barriers. HSA/FSA holders looking to use tax-advantaged health dollars on preventive screening find clear value in the test’s confirmed eligibility.

Users who may want to consider other options include people who already have regular physician visits with covered lab work (the convenience premium over insurance-covered testing may not be justified), anyone with a known lipid disorder requiring clinical-grade monitoring (finger-prick collection has slightly lower precision than venipuncture for certain markers), and users who need advanced lipid testing such as apolipoprotein B, Lp(a), or LDL particle number, which Everlywell’s standard panels do not include.

How the Everlywell Heart Health Test Compares

InsideTracker InnerAge 2.0 ($299) measures up to 20 biomarkers and calculates a biological age score with personalized recommendations tied to nutrition, exercise, and supplement interventions. It costs more but provides a broader biomarker panel and more sophisticated analytics. InsideTracker targets longevity enthusiasts willing to invest in a comprehensive baseline assessment.

LetsGetChecked Comprehensive Health ($149 to $299) offers similar finger-prick blood panels with the added benefit of nurse consultations for result interpretation. The nurse support adds a layer of clinical guidance that Everlywell’s physician review model does not match in terms of direct patient interaction. LetsGetChecked also offers international availability.

Quest Diagnostics Direct ($29 to $299 per panel) provides no-prescription-needed blood testing through Quest’s nationwide network of 2,200+ patient service centers. The key difference is that Quest uses standard venipuncture rather than finger-prick collection, which provides higher-precision results, particularly for lipid measurements. The trade-off is that Quest requires an in-person visit to a draw site rather than testing at home.

Limitations and Open Questions

Finger-prick dried blood spot collection, while validated for population screening, introduces more variability than standard venipuncture. Small sample volumes and user technique (insufficient blood, contamination, hemolysis from over-squeezing the fingertip) can affect result accuracy. Everlywell provides detailed instructions to minimize these issues, but user error remains a factor that clinical phlebotomy eliminates.

The standard Everlywell Heart Health panels do not include advanced cardiovascular biomarkers that the broader medical research community increasingly considers important for comprehensive risk assessment. Apolipoprotein B, lipoprotein(a), and LDL particle number provide risk information that standard LDL cholesterol cannot fully capture, particularly in patients with metabolic syndrome or discordant lipid profiles. Users relying solely on Everlywell’s standard panels may miss risk factors that more advanced testing would reveal.

Some Everlywell tests outside the heart health category, particularly food sensitivity panels based on IgG antibody measurements, have faced scientific criticism from major medical associations. While this does not directly affect the validity of the lipid and inflammatory marker panels, it raises questions about the company’s overall commitment to evidence-based test selection across its catalog.

Results without clinical context can create anxiety. A mildly elevated LDL reading, without a physician’s interpretation of the patient’s full risk profile, family history, and other factors, may prompt unnecessary worry or self-directed interventions that a clinician would not recommend.

What This Means for Your Health

Cardiovascular disease is the most lethal of The Four Villains that Healthcare Discovery‘s longevity framework identifies as the primary chronic disease threats: cardiovascular disease, cancer, neurodegenerative disease, and metabolic dysfunction. The biomarkers measured by the Everlywell Heart Health Test, particularly LDL cholesterol, hsCRP, and HbA1c, are among the most actionable early warning signals for two of these four threats (cardiovascular and metabolic dysfunction).

Within the Five Pillars framework, blood biomarker testing connects most directly to the Nutrition pillar. Lipid levels, inflammatory markers, and blood glucose regulation are all profoundly influenced by dietary patterns. A single Everlywell test can reveal whether your current nutritional approach is producing the metabolic environment that supports longevity or silently driving atherogenesis. This creates a feedback loop: test, adjust nutrition and movement patterns, retest, and verify that changes are producing measurable results.

The Movement pillar benefits as well. Regular exercise is one of the most potent interventions for raising HDL cholesterol, lowering triglycerides, improving insulin sensitivity, and reducing systemic inflammation. Quantifying these markers before and after establishing an exercise routine provides objective evidence of whether your training is producing cardiovascular benefit beyond weight and body composition changes.

The most important insight from at-home blood testing may be the simplest one: knowing your numbers. The gap between cardiovascular risk and cardiovascular awareness is enormous. For $99 and a finger prick, the Everlywell Heart Health Test gives you a starting point. What you do with that information, whether you adjust your nutrition, increase your movement, reduce your stress, or bring the results to a physician for deeper evaluation, determines whether the test was worth taking.

Frequently Asked Questions

How accurate is the Everlywell Heart Health Test?

Everlywell’s partner laboratories hold CLIA certification and process samples to federal proficiency standards. The dried blood spot collection method has been validated for lipid and HbA1c measurement and has been used in clinical research for over 30 years. However, finger-prick collection introduces slightly more variability than standard venipuncture (needle-drawn blood). Factors including sample volume, hemolysis from over-squeezing, and fasting compliance can affect results. For clinical-grade precision, especially for monitoring a known lipid disorder, venipuncture through a provider like Quest Diagnostics remains the reference standard.

Is the Everlywell Heart Health Test covered by insurance?

Everlywell tests are not typically covered by health insurance plans. However, all Everlywell tests are confirmed HSA (Health Savings Account) and FSA (Flexible Spending Account) eligible, which provides tax-advantaged purchasing for the millions of Americans with these accounts. The Heart Health Test starts at $99, and the tax savings from HSA/FSA payment effectively reduces cost by 20% to 35% depending on your tax bracket. No prescription or physician referral is needed to order.

What biomarkers does the Everlywell Heart Health Test measure?

The standard Everlywell Heart Health panel measures total cholesterol, LDL cholesterol (calculated), HDL cholesterol, and triglycerides. More comprehensive panels add high-sensitivity C-reactive protein (hsCRP), a key inflammation marker, and hemoglobin A1c (HbA1c), which reflects average blood glucose over 2 to 3 months. The combination provides screening data across lipid metabolism, systemic inflammation, and glucose regulation. The panels do not include advanced markers like apolipoprotein B, lipoprotein(a), or LDL particle number.

Do I need to fast before the Everlywell Heart Health Test?

Yes, Everlywell recommends fasting for 12 hours before collecting your blood sample for the Heart Health Test. Fasting ensures accurate measurement of triglycerides and LDL cholesterol, both of which are affected by recent food intake. Water is permitted during the fasting period. Most users find it easiest to collect their sample first thing in the morning before eating breakfast. Failure to fast properly can result in artificially elevated triglycerides and inaccurate LDL calculations.

Everlywell vs Quest Diagnostics for heart health testing?

Everlywell ($99 to $249) offers at-home finger-prick collection with mail-in processing and physician-reviewed digital results, with no in-person visit required. Quest Diagnostics Direct ($29 to $299 per panel) uses standard venipuncture at one of 2,200+ locations nationwide, providing higher-precision blood draws. Choose Everlywell for convenience and no-visit access. Choose Quest for maximum accuracy, especially if you are monitoring a known lipid disorder. Both are available without a prescription, and both are HSA/FSA eligible.

How often should I take the Everlywell Heart Health Test?

For baseline screening, a single test provides useful starting data. For ongoing monitoring, testing every 3 to 6 months allows you to track trends and measure the impact of lifestyle changes on your cardiovascular biomarkers. Quarterly testing ($396 to $996 per year depending on panel) provides the most actionable trend data. If you have a known cardiovascular condition or are on lipid-lowering medication, work with your physician for monitoring frequency rather than relying solely on at-home testing.

Free Daily Briefing

The Latest Longevity Science.
Delivered Every Morning.

Join researchers, physicians, and health professionals getting daily breakthroughs in AI-driven medicine, epigenetics, and longevity research.

Support the research that powers this editorial

Subscribe Free

No spam. Unsubscribe anytime. We respect your inbox.